Evidence map›Paper›PMID 42818039›Full record

ArticlebioRxiv : the preprint server for biology2026

A naturally occurring Tat R52W variant in brain-derived HIV attenuates transcription and may contribute to reservoir persistence.

Hongjie Chen, Nan Jiang, Yuyang Tang, Antoine Chaillon, Sara Gianella, David M Margolis, Venkat R Chirasani, Guochun Jiang

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hongjie ChenDepartment of Medicine and the UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 27599.
Nan JiangDepartment of Computer Science, University of Maryland at College Park, College Park, MD, USA 20742.
Yuyang TangDepartment of Medicine and the UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 27599.
Antoine ChaillonDepartment of Medicine, University of California at San Diego, La Jolla, CA, USA 92093.
Sara GianellaDepartment of Medicine, University of California at San Diego, La Jolla, CA, USA 92093.
David M MargolisDepartment of Medicine and the UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 27599.
Venkat R ChirasaniR. L. Juliano Structural Bioinformatics Core, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 27599.
Guochun JiangDepartment of Medicine and the UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 27599.

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
Structural Biology CoreU54AI170855 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Bruce Edward Torbett · 2022 to 2026
$36.7M
Collaboratory of AIDS Researchers for Eradication (CARE)UM1AI164567 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2021 to 2026
$31.6M
Defining the HIV reservoir and latency mechanism in human brain myeloid cellsR01MH136852 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Guochun Jiang · 2024 to 2026
$2.3M
Histone decrotonylation uniquely regulates HIV latencyR01AI186609 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Guochun Jiang · 2024 to 2026
$2.2M
Characterize replication competent myeloid reservoirs in the central nervous systemR21MH128034 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JIANG, GUOCHUN · 2021 to 2022
$443k
Novel Epigenetic Marks for HIV Latency Entry and ReversalR21AI167709 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JIANG, GUOCHUN · 2023 to 2024
$428k
NCI NIH HHS P30 CA016086NIAID NIH HHS R01 AI186609NIAID NIH HHS R21 AI167709NIAID NIH HHS U54 AI170855NIAID NIH HHS UM1 AI164567NIMH NIH HHS R01 MH136852NIMH NIH HHS R21 MH128034
6 · The paper itself

Abstract

HIV-1 persistence under suppressive antiretroviral therapy (ART) remains a major barrier to eradication, yet the contribution of naturally occurring viral variation to transcriptional regulation is incompletely understood. Here, we identify an HIV-1 Tat variant (R52W) that attenuates viral transcription through the disruption of the Tat-TAR RNA interaction. Full-length HIV-1 genomes derived from the brain microglia of a "Last Gift" donor, together with peripheral viral sequences obtained during suppressive ART, revealed the presence of the R52W variant

Indexed as

HIV-1 genomeHIV latencyHIV reservoirmicrogliaTARTat

Identifiers

PMID42818039
PMCPMC13622185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.